Liquidmetal Technologies Inc (LQMT)

[The Paraclete]

Right you are about Zyris. It's impact for shareholders is like a puff of smoke." But the impact for LQMT could be huge, in this sense: major companies are very unlikely to be the first ones to jump in the game and trust a company like LQMT to produce a part that is used in one of their own devices. So the success that LQMT has had with Zyris can attract larger fish, like ConMed ($796.4 Million in sales for 2017), which in turn will attract the likes of Johnson & Johnson ($25.1 Billion in sales), Medtronic ($20.2 Billion), GE Healthcare ($17.6 B), Siemens Healthcare ($14.5 B), Phillips Healthcare ($11.9 B)... and the list goes on and on.

As we say in China, a journey of a thousand miles begins with the first step.